Stock Research: Profound Medical

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Profound Medical

TSX:PRN CA74319B5027
18
  • Value
    32
  • Growth
    19
  • Safety
    Safety
    30
  • Combined
    1
  • Sentiment
    37
  • 360° View
    360° View
    18
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Profound Medical Corp. develops and markets customizable, incision-free therapies for diseased tissue ablation. It operates in the medical device industry, commercializing TULSA-PRO for prostate disease and Sonalleve for uterine fibroids and palliative pain. In the last fiscal year, the company had a market cap of $172 million, profits of $7 million, and revenue of $11 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 18 (better than 18% compared with alternatives), overall professional sentiment and financial characteristics for the stock Profound Medical are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with all four indicators below average for Profound Medical. The consolidated Value Rank has a low rank of 30 which means that the share price of Profound Medical is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 70% of alternative stocks in the same industry. The consolidated Growth Rank also has a low rank of 19, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is lower than for 19% of competitors in the same industry. The consolidated Safety Rank has a riskier rank of 32, which means that the company has a riskier financing structure than 68% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a low rank of 37, which means that professional investors are more pessimistic about the stock than for 63% of alternative investment opportunities. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
30 27 8 57
Growth
19 35 47 17
Safety
Safety
32 30 42 91
Sentiment
37 50 78 28
360° View
360° View
18 14 26 34
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
67 100 93 73
Opinions Change
31 28 50 50
Pro Holdings
n/a 8 49 14
Market Pulse
58 71 61 37
Sentiment
37 50 78 28
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
30 27 8 57
Growth
19 35 47 17
Safety Safety
32 30 42 91
Combined
1 1 10 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
23 23 23 12
Price vs. Earnings (P/E)
27 16 3 36
Price vs. Book (P/B)
52 45 27 96
Dividend Yield
1 1 1 1
Value
30 27 8 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
100 100 98 99
Profit Growth
10 17 50 29
Capital Growth
1 14 3 7
Stock Returns
19 41 49 9
Growth
19 35 47 17
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
76 69 66 83
Refinancing
67 51 65 83
Liquidity
4 4 11 9
Safety Safety
32 30 42 91

Similar Stocks

Discover high‑ranked alternatives to Profound Medical and broaden your portfolio horizons.

Russel Metals

TSX:RUS
Country: Canada
Industry: Trading & Distribution
Size: Medium
Full Stock Analysis

Canadian Utilities

TSX:CU
Country: Canada
Industry: Multi-Utilities
Size: Medium
Full Stock Analysis

Whitecap Resources

TSX:WCP
Country: Canada
Industry: Oil & Gas Production
Size: Medium
Full Stock Analysis

Envista Holdings

NYSE:NVST
Country: USA
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.